What’s new

• Vijaya Diagnostics appointed Narasimha Raju K.A. as CFO, effective July 09, 2026.
• Raju previously served as CFO from March 2021 to March 2025 and led the company's COVID-era IPO.
• He joins from Yashoda Group of Hospitals after a short gap.

Why it matters

This is not a surprise hire. Raju is a known entity who already knows the company's financial structure and capital markets strategy. For a large-cap diagnostic chain with no debt and steady growth, it removes any uncertainty about the finance function's continuity. But it changes nothing about the business trajectory today.

What we’re watching

• Any strategic moves Raju may accelerate, given his earlier IPO experience.
• Management commentary on expansion or acquisition plans in upcoming quarters.
• Whether the board fills any other open leadership roles.

The full read

Vijaya Diagnostic Centre’s board has reappointed Narasimha Raju K.A. as CFO, effective July 09, 2026. Raju previously held the same role from March 2021 to March 2025, overseeing the company’s ₹14,074 cr market-cap chain through its COVID-era IPO. He is a chartered accountant with 20+ years of experience across healthcare, renewable energy, and real estate. The appointment is routine — Raju is a known quantity, and the position was vacant since his departure. For a company with zero debt, 26.6% trailing revenue growth, and 18% ROE, this fills a governance gap without shifting fundamentals. It’s a continuity hire, not a catalyst.

Primary source: BSE · NSE